Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.
Kristyn GalbraithMekka GarciaSiyu WeiAnna ChenChanel SchroffJonathan SerranoDonato PacioneDimitris G PlacantonakisChristopher M WilliamArline FaustinDavid ZagzagMarissa BarbaroMaria Del Pilar Guillermo Prieto EiblMitsuaki ShirahataDavid ReussQuynh T TranZahangir AlomAndreas von DeimlingBrent A OrrErik P SulmanJohn G GolfinosDaniel A OrringerRajan JainEvan LiebermanYang FengMatija SnuderlPublished in: Neuro-oncology (2024)
The current WHO recognized grading criteria for IDH mutant astrocytomas show limited prognostic value. Stratification based on DNA methylation shows superior prognostic value for OS.